4 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Biogen's New Study to Test Higher Dose of SMA Drug Spinraza http://www.zacks.com/stock/news/526375/biogens-new-study-to-test-higher-dose-of-sma-drug-spinraza?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526375 Sep 19, 2019 - Biogen (BIIB) starts a DEVOTE study to investigate whether a higher dose of Spinraza can provide greater efficacy for treating patients with spinal muscular atrophy.
Novartis Announces New Data on Spondylitis Drug Cosentyx http://www.zacks.com/stock/news/522872/novartis-announces-new-data-on-spondylitis-drug-cosentyx?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-522872 Sep 17, 2019 - Novartis (NVS) announces new positive data from a phase III study on Cosentyx in patients with active nr-axSpA.
J&J Files sBLA for Tremfya With FDA for Psoriatic Arthritis http://www.zacks.com/stock/news/522810/jj-files-sbla-for-tremfya-with-fda-for-psoriatic-arthritis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-522810 Sep 17, 2019 - J&J's (JNJ) sBLA seeking approval for Tremfya for active psoriatic arthritis is based on data from the phase III DISCOVER 1 and 2 studies.
Breast Cancer Drugs May Inflame Lungs Per FDA Safety Alert http://www.zacks.com/stock/news/520833/breast-cancer-drugs-may-inflame-lungs-per-fda-safety-alert?cid=CS-ZC-FT-analyst_blog|industry_focus-520833 Sep 16, 2019 - The FDA approves new warnings about inflammation risk to be added to labels of Pfizer's (PFE) Ibrance, Eli Lilly's (LLY) Verzenio and Novartis' (NVS) Kisqali.

Pages: 1

Page 1